Brian R. Overholser

1.9k total citations
64 papers, 1.2k citations indexed

About

Brian R. Overholser is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Brian R. Overholser has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 18 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Brian R. Overholser's work include Cardiac electrophysiology and arrhythmias (30 papers), Ion channel regulation and function (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Brian R. Overholser is often cited by papers focused on Cardiac electrophysiology and arrhythmias (30 papers), Ion channel regulation and function (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Brian R. Overholser collaborates with scholars based in United States, India and Saudi Arabia. Brian R. Overholser's co-authors include Kevin M. Sowinski, James E. Tisdale, Richard J. Kovacs, Joanna R. Kingery, Tate N. Trujillo, Heather A. Jaynes, Michael Kays, Heather A. Wroblewski, Meg Kays and John C. Lopshire and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brian R. Overholser

61 papers receiving 1.2k citations

Peers

Brian R. Overholser
G Cheymol France
Umesh Shukla United States
S. Harder Germany
Thomas G. Wells United States
Brian R. Overholser
Citations per year, relative to Brian R. Overholser Brian R. Overholser (= 1×) peers Agnès Sommet

Countries citing papers authored by Brian R. Overholser

Since Specialization
Citations

This map shows the geographic impact of Brian R. Overholser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian R. Overholser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian R. Overholser more than expected).

Fields of papers citing papers by Brian R. Overholser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian R. Overholser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian R. Overholser. The network helps show where Brian R. Overholser may publish in the future.

Co-authorship network of co-authors of Brian R. Overholser

This figure shows the co-authorship network connecting the top 25 collaborators of Brian R. Overholser. A scholar is included among the top collaborators of Brian R. Overholser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian R. Overholser. Brian R. Overholser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinney, Sara K., et al.. (2025). QTc Interval Changes in Preeclampsia vs. Normal Pregnancy: A Systematic Review and Meta‐Analysis. Clinical Pharmacology & Therapeutics. 117(6). 1650–1660.
2.
Overholser, Brian R., et al.. (2024). Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction. PLoS ONE. 19(8). e0308999–e0308999. 3 indexed citations
3.
Packiasabapathy, Senthil, Blessed Winston Aruldhas, Pengyue Zhang, et al.. (2021). Novel Associations Between Cyp2B6 Polymorphisms, Perioperative Methadone Metabolism and Clinical Outcomes in Children. Pharmacogenomics. 22(10). 591–602. 9 indexed citations
4.
Shao, Minghai, et al.. (2019). MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation. PMC. 1 indexed citations
5.
Kiel, Patrick J., Brian R. Overholser, Anthony L. Sinn, et al.. (2019). Olaparib Induced Moderate Killing of ATM-Deficient Mantle Cell Lymphoma Cells In Vitro and In Vivo. IUScholarWorks (Indiana University). 1 indexed citations
6.
Melton, Brittany L., Alan J. Zillich, Jason J. Saleem, et al.. (2016). Iterative Development and Evaluation of a Pharmacogenomic-Guided Clinical Decision Support System for Warfarin Dosing. Applied Clinical Informatics. 7(4). 1088–1106. 17 indexed citations
7.
Lu, Jessica Bo Li, Heather A. Jaynes, Jason Robarge, et al.. (2016). Efavirenz inhibits the human ether-a-go-go related current (hERG) and induces QT interval prolongation in CYP2B6*6*6 allele carriers. PMC. 5 indexed citations
8.
Tisdale, James E., Heather A. Jaynes, Brian R. Overholser, et al.. (2016). Influence of Oral Progesterone Administration on Drug-Induced QT Interval Lengthening. JACC. Clinical electrophysiology. 2(7). 765–774. 12 indexed citations
9.
10.
Tisdale, James E., Heather A. Wroblewski, Joanna R. Kingery, et al.. (2012). EFFECTIVENESS OF A CLINICAL DECISION SUPPORT SYSTEM INCORPORATING A VALIDATED QT INTERVAL PROLONGATION RISK SCORE FOR REDUCING THE RISK OF QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS. Journal of the American College of Cardiology. 59(13). E1799–E1799. 2 indexed citations
11.
Tisdale, James E., Heather A. Wroblewski, Brian R. Overholser, et al.. (2012). Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs. Drug Safety. 35(6). 459–470. 63 indexed citations
12.
Campbell, Noll L., et al.. (2011). A Retrospective Cohort Study of a Nurse-Driven Computerized Insulin Infusion Program Versus a Paper-Based Protocol in Critically Ill Patients. Diabetes Technology & Therapeutics. 14(2). 125–130. 12 indexed citations
13.
Tisdale, James E., Heather A. Wroblewski, Joanna R. Kingery, et al.. (2011). A RISK SCORE TO PREDICT QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS. Journal of the American College of Cardiology. 57(14). E112–E112. 2 indexed citations
14.
Wroblewski, Heather A., James E. Tisdale, Joanna R. Kingery, Brian R. Overholser, & Richard J. Kovacs. (2010). PREVALENCE OF QTC INTERVAL PROLONGATION IN PATIENTS ADMITTED TO CARDIAC CRITICAL CARE UNITS AND FREQUENCY OF SUBSEQUENT ADMINISTRATION OF QT INTERVAL PROLONGING DRUGS. Journal of the American College of Cardiology. 55(10). A1.E10–A1.E10. 1 indexed citations
15.
Overholser, Brian R., et al.. (2010). Sudden death in the presence of overt β-adrenergic receptor activation in guinea pigs immediately following isoflurane anesthesia. Veterinary Anaesthesia and Analgesia. 37(3). 273–279. 3 indexed citations
16.
Tisdale, James E., Brian R. Overholser, Heather A. Wroblewski, & Kevin M. Sowinski. (2010). The Influence of Progesterone Alone and in Combination With Estradiol on Ventricular Action Potential Duration and Triangulation in Response to Potassium Channel Inhibition. Journal of Cardiovascular Electrophysiology. 22(3). 325–331. 8 indexed citations
17.
Overholser, Brian R., et al.. (2008). Catecholaminergic Effects on Ventricular Repolarization During Inhibition of the Rapid Component of the Delayed Rectifier Potassium Current in a Perfused Heart Model. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(11). 1315–1324. 4 indexed citations
18.
Foster, David R., Kevin M. Sowinski, H.‐H. Sherry Chow, & Brian R. Overholser. (2007). Limited Sampling Strategies to Estimate Exposure to the Green Tea Polyphenol, Epigallocatechin Gallate, in Fasting and Fed Conditions. Therapeutic Drug Monitoring. 29(6). 835–842. 11 indexed citations
19.
Zhang, Xin, Brian R. Overholser, Michael Kays, & Kevin M. Sowinski. (2006). Gatifloxacin Pharmacokinetics in Healthy Men and Women. The Journal of Clinical Pharmacology. 46(10). 1154–1162. 3 indexed citations
20.
Overholser, Brian R., Donald F. Brophy, & Kevin M. Sowinski. (2006). Development of an Efficient Sampling Strategy to Predict Enoxaparin Pharmacokinetics in Stage 5 Chronic Kidney Disease. Therapeutic Drug Monitoring. 28(6). 807–812. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026